PTC Therapeutics, Inc. Common Stock (NASDAQ: PTCT) last traded at $69.82, down 0.99% on the session. The quote above updates while this page is open; the figures below are drawn from PTC Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
PTC Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker PTCT. Its market capitalisation is $5.83 billion.
Valuation measures for PTC Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.83B |
|---|---|
| Enterprise value | $8.19B |
| Price / sales | 5.78 |
| Beta | 0.73 |
Trailing-twelve-month figures tagged in PTC Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.01B |
|---|---|
| Net income (TTM) | -$38.38M |
| EPS (TTM) | -$0.540 |
| Operating margin | 12.45% |
| Cash | $1.05B |
Range and volume for PTCT over the past 52 weeks.
| 52-week high | $90.87 |
|---|---|
| 52-week low | $48.28 |
| Volume | 674.7K |
| Average volume | 1.70M |
| Previous close | $70.52 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.